申请人:Shibata Hisashi
公开号:US08431603B2
公开(公告)日:2013-04-30
A compound represented by the following formula (I), or salt thereof exhibits excellent CRF receptor antagonism, and sufficient pharmacological activity, safety and pharmacokinetic properties as a drug.
wherein R1 represents the formula -A11-A12; R2 represents tetrahydrofurylmethyl, tetrahydropyranylmethyl or tetrahydropyranyl; A11 represents a single bond, methylene or 1,2-ethylene; A12 represents C1-6 alkyl, C3-6 cycloalkyl or C3-6 cycloalkyl having methyl; R3 represents methoxy, cyano, cyclobutyloxymethyl, methoxymethyl or ethoxymethyl; and R4 represents methoxy or chlorine.
以下化学式(I)所代表的化合物或其盐,表现出优异的CRF受体拮抗作用,并具有足够的药理活性、安全性和药代动力学特性作为药物。其中,R1代表式-A11-A12;R2代表四氢呋喃甲基、四氢吡喃甲基或四氢吡喃基;A11代表单键、亚甲基或1,2-乙烯基;A12代表C1-6烷基、C3-6环烷基或带有甲基的C3-6环烷基;R3代表甲氧基、氰基、环丁氧甲基、甲氧甲基或乙氧甲基;R4代表甲氧基或氯。